跳至主要内容
临床试验/NCT00231062
NCT00231062已完成3 期

Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)

Integra LifeSciences Corporation0 个研究点目标入组 115 人开始时间: 2005年4月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
115
主要终点
Number of Sinuses With Patency of Sinus Ostium After Sinuplasty

研究概览

简要总结

A multi-center, non-randomized, prospective post-market evaluation of sinuplasty in paranasal sinuses.

详细描述

Sinusitis is a common healthcare problem that significantly reduces quality of life for people around the world. Patients suffer from headache, facial discomfort, nasal congestion, nasal drainage, loss of the sense of smell and malaise. Sinusitis is responsible for major healthcare expenditure and loss of workplace productivity.

The rationale of this study is to collect data on the effectiveness and safety of balloon dilation of the Frontal, Maxillary and Sphenoid sinuses by treating patients and observing them for a six month period of time following the procedure. Six month follow-up data is important to demonstrate the effectiveness of balloon catheter dilation.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years and greater
  • Both male and female patients eligible
  • Diagnosis of chronic sinusitis that is not responsive to medical management
  • Planned endoscopic sinus surgery (recommended by PI, consented to by patient)

排除标准

  • Extensive sinonasal polyps
  • Extensive previous sinonasal surgery
  • Extensive sinonasal osteoneogenesis
  • Cystic fibrosis
  • Sampter's Triad (Aspirin sensitivity, Asthma, Sinonasal polyposis)
  • Sinonasal tumors or obstructive lesions
  • History of facial trauma that distorts sinus anatomy and precludes access to the sinus ostium
  • Ciliary dysfunction
  • Pregnant females

结局指标

主要结局

Number of Sinuses With Patency of Sinus Ostium After Sinuplasty

时间窗: 24 weeks

Patency of sinus ostium after sinuplasty will be determined by nasal endoscopic examination. The investigator will make a clinical judgment as to whether or not this has been achieved.

Number of Participants With Adverse Events Following Sinuplasty Procedure

时间窗: 24 weeks

Adverse event rate at 24 weeks: comprised of all observed peri-operative adverse events which were recorded on dedicated CRFs and any observed or patient-reported post-operative adverse events will be similarly recorded (through 24 week follow-up).

次要结局

  • Number of Participants Experiencing Relief of Sinus Symptoms(Week 24)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Clinical Evaluation to Confirm Safety and Efficacy... | 临床试验